America's pharmacists remain steadfast in support of a bipartisan bill that could dramatically change their segment of the nation's healthcare industry at the federal level. Read More »
The U.S. Food and Drug Administration (FDA) on Tuesday approved Novartis' Entresto tablets for the treatment of heart failure.Heart failure is a common condition that affects approximately 5.1 million people in the United States. Read More »
Recertification credit hours will be offered at Midyear Clinical Meeting in New Orleans. Read More »
Deadline extended until Nov. 1 to give health systems more time to comply. Read More »
Three pharmacy organizations have asked the U.S. Food and Drug Administration (FDA) to delay enforcement of the "track & race" requirement. Read More »
Johns Hopkins Bloomberg School of Public Health research suggests many primary care physicians don’t understand facts on the abuse of prescription pain medications or how addictive formulations can be, which may be contributing to the epidemic of prescription opioid abuse. Read More »
The U.S. Food and Drug Administration (FDA) and international regulatory and law enforcement agencies acted this week against more than 1,050 websites illegally selling unapproved prescription medications and medical devices. Read More »
A letter signed by more than 20 Democratic lawmakers, calling for black box labels to be put on immediate-release (IR) opioids, has been sent to acting FDA commissioner Stephen Ostroff. Read More »
The Academy of Managed Care Pharmacy (AMCP) brought together health care leaders for a two-day conference in Alexandria, Virginia, this week to discuss issues pertaining to market readiness, acceptance and use of biosimilars. Biosimilars consist of living molecules that are versions of biological therapies. Read More »
Specialty health care services provider Intralign Health LLC recently entered into a physician participation agreement with Care First Blue Cross Blue Shield. Read More »
Aspyrian Therapeutics and Goodwin Biotechnology said on Tuesday that they will collaborate on the development and scaling processes of Aspyrian's new antibody drug conjugate (ADC) platform. Aspyrian's platform is a near-infrared photo-immunotherapy technological platform that uses a laser of visible light to eliminate tumors and leave surrounding healthy tissue unharmed. Read More »
Officials from more than 150 food companies, retailers and human and animal health stakeholders attended the recent White House Forum on Antibiotic Stewardship to make public their commitments to making changes over the next five years: to stem the development of antibiotic-resistant bacteria, find resistant strains, preserve the potency of antibiotics already in use and quell the spread of resistant infections. Read More »
Bill includes potential cuts that would make it harder to access health care services Read More »
The Centers for Medicare and Medicaid Services (CMS) said last week that new, privacy-protected data on Medicare Part D prescription drugs prescribed by physicians and other health care professionals in 2013 is now available. Read More »
With two Baltimore CVS locations burned and eight Rite Aid sites damaged by fire or looting, the Baltimore City Health Department is spearheading efforts via the city’s 311 system to help impacted residents acquire their medications. Read More »
The U.S. Food and Drug Administration (FDA) has approved ApexM to be sold over the counter to treat stress, urge and mixed urinary incontinence in women. Read More »
U.S. Chamber of Commerce's Institute for Legal Reform says change would lead to higher consumer costs. Read More »
President and Congress agree making high-cost drugs available to all patients a priority Read More »
Sandoz receives approval to market Glatopa. Read More »
Regulatory Compliance Associates (RCA), a life-sciences consultancy, said on Thursday that its cooperative effort with Unique Pharmaceuticals will help the latter demonstrate compliance with new federal compounding industry regulations. “We’re proud to partner with Unique Pharmaceuticals as they lead the compounding pharmacy industry in demonstrating their commitment to quality,” Andrew Harrison, chief regulatory affairs officer at RCA, said. Read More »
Alerts Sign-up